US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 14.540
  • +0.180+1.25%
Close Mar 28 16:00 ET
  • 14.540
  • 0.0000.00%
Post 16:05 ET
376.69MMarket Cap-3.24P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 687.500K--
--2025/Q1-- / 687.500K--
--2024/Q4-759.000K / 100.000K--
--2024/Q3387.000K / 1.833M--
--2024/Q233.445M / 5.506M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 687.500K--
--2025/Q1-- / 687.500K--
--2024/Q4-759.000K / 100.000K--
--2024/Q3387.000K / 1.833M--
--2024/Q233.445M / 5.506M--

Unlock Free Earnings Estimates

Cartesian Therapeutics Earnings Reports

  • Cartesian Therapeutics | 10-K: FY2024 Annual Report

    Mar 13 07:07 ET

  • Cartesian Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 07:23 ET

  • Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7, 2024 07:08 ET

  • Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 07:09 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +10.49%
    eBay
    EBAY
    +0.52%
    Collegium Pharmaceutical
    COLL
    +0.51%
    Dorian LPG
    LPG
    +0.31%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 18, 2025

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data